New biopsy technique could improve pancreatic cancer diagnosis

NCT ID NCT04165018

Completed Knowledge-focused Sponsor: Baylor College of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a newer biopsy method called fine-needle biopsy (FNB) for diagnosing pancreatic masses. Researchers wanted to see if FNB could provide better tissue samples than the standard fine-needle aspiration (FNA) without needing a cytologist on site. Fifty-two adults with pancreatic masses underwent FNB, and the team measured how well the samples worked for diagnosis and tracked any side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Fine-needle biopsy (FNB) procedure
What this could lead to: If successful, this could show that FNB is a better, more cost-effective way to diagnose pancreatic masses, potentially replacing the older FNA method.
What could go wrong: This is a small, completed study with only 52 participants, so results may not apply to all patients. The procedure still carries risks like bleeding or pancreatitis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC NEOPLASMS

Contacts and locations

Locations

Baylor College of Medicine

Houston, Texas, 77030, United States
Baylor St. Lukes Medical Center (BSLMC)

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.